Symposium 2011: Friday Schedule


Friday Schedule Friday Saturday Thursday

Defining Value in Cancer Care
12:30-5:00 pm, December 2, 2011

Registration: 12:30 pm
Program: 1:00 - 5:00 pm
Please join us for a reception following the program.

Georgetown University Law Center
Bernard P. McDonough Hall, Hart Auditorium
600 New Jersey Avenue NW, Washington, DC 20001

12:30 pm - Registration
1:00 pm - Introduction
Cancer Care 2011: The Cost of Care in the U.S. and its Impact

M. Gregg Bloche, MD, JD
Professor of Law, Georgetown University Law Center,
Co-Director, Georgetown-Johns Hopkins Joint Program in Law and Public Health

1:10 pm
Setting the Stage: $124 Billion Spent, to What Return?

Antonio Tito Fojo, MD, PhD
Head, Experimental Therapeutics Section
Senior Investigator, Medical Oncology Branch Affiliates, The Center for Cancer Research, National Cancer Institute, U.S. National Institutes of Health

1:30 pm
Bending the Cost Curve in Cancer

Thomas Smith, MD, FACP
Director of Palliative Medicine, Johns Hopkins Medical Institutions
Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center


1:50 pm
Question/Answer Session

Moderator: John Marshall, MD
Director, Ruesch Center for the Cure of GI Cancers
Chief, Division of Hematology/Oncology
Associate Director, Georgetown Lombardi Comprehensive Cancer Center


2:00 pm
The Gatekeepers: Safety and Efficacy vs. Value

Gregory Reaman, MD
Associate Director, Office of Oncology Drug Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration


2:15 pm
The Impact of Guideline Based Medicine, the NCCN Process and Perspective

Jordan Berlin, MD
Professor of Medicine, Vanderbilt University School of Medicine
Clinical Director, GI Oncology Program & Medical Director, Clinical Trials Shared Resources, Vanderbilt-Ingram Cancer Center

2:30 pm

Moderator: M. Gregg Bloche, MD, JD
Professor of Law, Georgetown University Law Center
Co-Director, Georgetown-Johns Hopkins Joint Program in Law and Public Health

Private Insurance: Why Paying for Cancer Care Makes “Business” Sense

Ira Klein, MD, MBA, FACP
Chief of Staff, Office of the Chief Medical Officer
National Accounts Clinical Sales & Strategy, Aetna, Inc.

J. Russell Hoverman, MD, PhD
Vice President of Managed Care, Texas Oncology
Medical Director of Managed Care and Disease Management
The US Oncology Network

Medicare/CMS: Unlimited Access vs. Governmental Controls

Louis Jacques, MD
Director, Coverage & Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare & Medicaid Services, U.S. Department of Health & Human Services

3:00 pm - Break

3:15 pm
Measuring Value in Cancer: U.S. & Global

Moderator: Arnold Potosky, PhD
Director of Health Services Research, Georgetown Lombardi Comprehensive Cancer Center

Comparative Effectiveness in the U.S.

Paul Wallace, MD
Senior Vice President, Director, Center for Comparative Effectiveness Research, The Lewin Group

Global Perspective

Mona Sabharwal, PharmD
Executive Director, Pan-Canadian Oncology Drug Review

Value Decisions in Drug Development

Arthur “Art” Small, MD
Head, Oncology Outcomes Research, U.S. Medical Affairs, Biometrics, Health Outcomes & Payer Support, Genentech, Inc.

Defining Value: The Individual vs. the Group

Margaret “Mimi” Mahon, PhD, RN, FAAN
Palliative Care Nurse Practitioner
Associate Professor, School of Nursing, George Mason University, College of Health & Human Services

4:00 pm

The Stakeholders’ Perspectives: What Do We Want in the Clinic?

Moderator: Ellen Sigal, PhD
Chairperson and Founder, Friends of Cancer Research

Featuring Ruesch Center Advocacy Board Members:

Carolyn R. “Bo” Aldigé
President and Founder, Prevent Cancer Foundation

Carlea Bauman
President, Fight Colorectal Cancer

Lucile Adams-Campbell, PhD
Associate Dean, Community Health and Outreach, Associate Director, Minority Health and Health Disparities Research, Georgetown Lombardi Comprehensive Cancer Center

Julie Fleshman, JD, MBA
President and Chief Executive Officer, Pancreatic Cancer Action Network

Gilad Gordon, MD, MBA
President, ORRA Group, LLC

Jasmine Greenamyer
Chief Operating Officer, Colon Cancer Alliance

Mace Rothenberg, MD
Senior Vice President, Clinical Development & Medical Affairs, Oncology Business Unit, Pfizer, Inc.

Michael Sapienza
Executive Director and Chairman of the Board, Chris4Life Colon Cancer Foundation

5:00 pm - Reception